baber/WOPTO huggingface dataset:
Patent NZ-541603-A (NZ)
Title: Carbonyl phenyl propanoic acid derivative compounds
Inventor: ASADA MASAKI
IPC: A61P17/02
Filed: 2004-02-06
Abstract: A carboxylic acid compound represented by general formula (I), its pharmaceutically acceptable salt, a process for producing the same and a drug containing the same as the active ingredient are disclosed: wherein R1 represents H or C1-4 alkyl; m is 2 or 3; n is an integer of from 0 to 2; R2 represents phenyl, naphthyl, benzofuran or benzothiophene; Q represents -CH2-O-Cyc1, -CH2-Cyc2 or -L-Cyc3; and R3a and R3b independently represent each hydrogen or C1-4 alkyl, or R3a and R3b represent together tetrahydro-2H-pyrane. Because of having antagonism specifically to PGE2 receptors (in particular, EP3 receptor which is one of the subtypes thereof), compounds represented by the general formula (I) are useful in preventing and/or treating itching, pain, urinary disorder or stress-induced diseases.
Patent NZ-542234-A (NZ)
Title: Cheese production process
Inventor: TAKAHASHI KIYOTAKA
IPC: A23C19/08
Filed: 2004-04-27
Abstract: A cheese production process is disclosed. The cheese production process comprises: (a) stretching cheese curds in hot water; and (b) contacting the cheese curds and a casein phospho oligopeptide capable of binding or adsorbing calcium either before or simultaneously with the stretching.
Patent NZ-544725-A (NZ)
Title: Articulated endoprosthesis
Inventor: LECHMANN BEAT
IPC: A61F2/00
Filed: 2003-07-22
Abstract: The disclosure relates to an articulated endoprosthesis, especially an intervertebral implant (1) comprising a central axis (2), an upper part (10), a lower part (20), and a joint (5) arranged thereinbetween. According to the invention, A) said joint (5) comprises at least two joint surfaces A and B that can be slid over each other; B) the upper part (10) has an upper apposition surface (15) intersecting the central axis (2) in addition to lateral surfaces the lower part (20) has a lower apposition surface (25) intersecting the central axis (2) in addition to lateral surfaces. The articulated endoprosthesis has at least one channel suitable for transporting body fluid, ending in one of the two joint surfaces A and B, and connecting the same to the outside of the articulated endoprosthesis.
Patent NZ-546730-A (NZ)
Title: Medication holder
Inventor: WHARTON DAVID PETER
IPC: A61M15/00
Filed: 2004-09-24
Abstract: A medication holder is disclosed comprising a housing (10) having an outer wall (12) and an inner wall (11) preferably in sleeved relationship to each other. The outer wall may be moved between a closed position in which the housing (10) is sealed for ingress of moisture or other contaminants and an open position providing access to the medication container discharge outlet. The second wall may (12) be slid longitudinally or rotated circumferentially to access the cavity and may, in the process, open an air pathway through the cavity. The medication container is preferably a pressurised canister (22). Alternatively, it may comprise a frangible vial (603) with a volatile liquid. In the latter case, an evaporation grid (563) may also be supplied to enhance absorption of the liquid which is preferably methoxyfluorane. Opening means (561) may be provided to open the frangible vial and discharge the contents onto the evaporation means (563) which is in fluid contact with the air pathway (806). A medication chute (26) may be rotatable between stowed and deployed positions. The chute (26) may include an auxiliary air inlet (556). The medication holder may also include one-way valves (605) to channel inspiratory air through the chamber and direct expiratory air elsewhere. The expiratory air may pass through unidirectional valve (810) and also through an absorbent filter (805) to minimise environmental contamination.
Patent NZ-547256-A (NZ)
Title: Combination of flupirtine and tramadol
Inventor: MAUS JOACHIM
IPC: A61K31/445
Filed: 2004-12-09
Abstract: Disclosed is the use of flupirtine in combination with tramadol or their respective physiologically acceptable salts for the manufacture of a medicament for the treatment of pain caused by indications selected from cancer, rheumatism, low back syndrome, ischio-Iumbalgia and those resulting from spinal cord injuries, osteoporosis, rigidity I spasticity or euralgia I neuropathy, episodic (tension), headache, migraine, post-surgical, post-traumatic, dental, lower spastic paraperesis syndrome, tetrapareses, biliary, or renal colic.
Patent NZ-550811-A (NZ)
Title: Certain chemical entities, compositions, and methods
Inventor: QIAN XIANGPING
IPC: C07C259/18
Filed: 2005-05-06
Abstract: Disclosed is a compound selected from N-(1-{4-[2-(1-acetylamino-ethyl)-1-ethyl-1-H-imidazol-4-yl]-benzyl}-3-hydroxypropyl)-3-chloro-4-(2,2,2-trifluoro-1-methyl-ethoxy)benzamide, N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1 ,2a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide, N-(1-{4-[2-(1-methyl-1-hydroxy-ethyl)-1-ethyl-1-H-imidazol-4-yl]-benzyl}-3-hydroxy-propyl)-3-chloro-4-(2,2,2-trifluoro-1-methyl-ethoxy)-benzamide, N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-methyl-imidazo[1,2-a]pyridin-2-yl]benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide, N-(1-{4-[2-(1-hydroxy-1-methyl-ethyl)-1-methyl-1-H-imidazol-4-yl]-benzyl}-3-hydroxy-propyl)-3-chloro-4-(2,2,2-trifluoro-1-methyl-ethoxy)-benzamide, N-(2-(2-amino-2-methyl-propionylamino)-1-{4-[8-methyl-imidazo[1 ,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide, and N-{1-[4-(8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl)-benzyI]-3-hydroxy-propyl}-3-chloro-4-isopropoxy-benzamide,or a pharmaceutically acceptable salt thereof. Also disclosed are further compounds, pharmaceutical compositions comprising said compounds, the use of said compound in the preparation of a pharmaceutical composition for the treatment of a cellular proliferative disease.
Patent NZ-552512-A (NZ)
Title: Energy efficient, inexpensive extraction of oxygen from ambient air for portable and home use
Inventor: UNGER REUVAN Z-M
IPC: F25J1/00
Filed: 2005-06-08
Abstract: An apparatus for separating oxygen from air and supplying the oxygen for use at atmospheric pressure is disclosed. The apparatus includes: (a) a vessel for confining gases; (b) an ambient air input including an ambient air inlet passage leading from the atmosphere to the vessel; (c) a cryocooler having a cooled surface in the vessel for directly condensing oxygen from the air, which has a control system for cooling the cold surface to a temperature greater than the boiling point temperature of nitrogen and not greater than the boiling point temperature of oxygen for condensing oxygen from air in the vessel; (d) a liquid/gas separator connected to the vessel to receive liquid oxygen drained from the cooled surface and separate the liquid from residual gases remaining in the vessel; (e) an oxygen output including an oxygen outlet passage connected to a liquid output of the separator for directing oxygen away from the vessel; (f) a residual gases output including a residual gas outlet passage connected to a gas output from the separator for exhausting residual gases from the vessel at substantially atmospheric pressure; (g) an air impeller for propelling air through the ambient air inlet passage, the residual gas passage and the vessel, the impeller developing a pressure gradient of less than 1 bar; (h) a heat exchanger having at least two passages separated by a gas impervious, thermally conductive wall for conducting heat from gas in a first passage to gas in a second passage, the first heat exchanger passage being connected in the air input passage and the second passage being connected in the residual gas outlet passage for transferring heat from incoming air to outgoing residual gases in which the heat exchanger is connected as a counter flow head exchanger; and (i) a water passage connected in communication with the first passage of the heat exchanger for draining water condensed in the ambient air inlet passage wherein the water passage is connected to one of the outlet passages for returning water to an outgoing gas.
Patent NZ-552841-A (NZ)
Title: Controlled release dosage form comprising two layers, wherein the delay layer is substanially free of non-microencapsulated drug
Inventor: CASADEVALL GEMMA
Filed: 2005-08-02
Abstract: Disclosed is a dosage form for sustained release of a drug comprising: a delay layer comprising (i) a polymeric matrix, and (ii) microencapsulated drug, wherein the delay layer is substantially free of non-microencapsulated drug; and a second layer comprising (iii) a polymeric matrix, and (iv) non-microencapsulated drug matrix; wherein the second layer is located adjacent to the delay layer.
Patent NZ-555874-A (NZ)
Title: System and method of providing a geographic view of nodes in a wireless network
Inventor: KUMAR NAVANEET
IPC: H04M11/00
Filed: 2005-12-15
Abstract: A method for providing a geographic view of nodes in a wireless network is disclosed. The method first comprises receiving geographic location data and operating status data for the nodes in the wireless network comprising a collector and multiple meters that communicate wirelessly with the collector. Each of the meters has a wireless communication path to the collector that is either a direct path or an indirect path through one or more intermediate meters that serve as repeaters. The wireless communication paths between each meter and the collector define a layout of the network. The geographic location data comprises a digital land parcel for each node. The method further comprises associating each node with a corresponding geographic location by computing a center point of the node's digital land parcel and associating the node with the computed center point; and rendering a geographic view of the nodes overlaying an aerial photograph. The geographic view displays each of the nodes at their corresponding geographic location on the aerial photograph. The geographic view further displays the operating status data directly within the geographic view without first requiring interaction with an item in the geographic view.
Patent NZ-556582-A (NZ)
Title: A tetracycline metal complex in a solid dosage form
Inventor: DEVRIES TINA
IPC: A61K9/16
Filed: 2006-01-20
Abstract: Disclosed is a solid dosage form comprising a metal complex of a tetracycline of Formula (I), for pharmaceutical administration, wherein R1 = N(CH3)2; R2 = H; R3 = H; and R4 = H, wherein the complex consists of minocycline and a metal. Also disclosed is a process to make said dosage form, the use of the complex in the manufacture of a said solid dosage form for treating a bacterial infection.
Patent NZ-570321-A (NZ)
Title: A structure where the expansion of boards is absorbed by a biasing means between the boards and a frame
Inventor: GIFFORD JOHN STEPHEN
IPC: E04B1/68
Filed: 2008-08-05
Abstract: A board structure is disclosed. The structure allows for the expansion of boards that it is constructed from. Internal stress is absorbed in the structure so that the components do not warp, split or work free of fastenings. The structure includes a plurality of boards (2, 16) aligned with each other within a plane. The planks (2, 16) are bounded at the top (8) and bottom by a rail. Each board is provided with a channel (9), through which a guide (11) passes, linking the planks (2, 16) and spanning between the rails (8). The guide (11) allows movement of the boards (2, 16) within the plane but constrains the boards (2, 16) to the plane. A resilient biasing means (17) acts against the boards (2, 16) and is positioned between the boards (2, 16) and at least one of the rails (8) such that the biasing means (17) acts against the boards (2, 16) and the rail (8). The rail (8) may be recessed to accommodate the guide (11) and biasing means (17). The boards (2, 16) may be separated by an elastomeric washer (20). The ends of the boards (2, 16) may also be constrained within grooves in side stays. The boards (2, 16) may run vertically, in which case the direction of board bias would be horizontal.
Patent NZ-579752-A (NZ)
Title: Clamping crew with a ball in the end for use in an electrical terminal
Inventor: STAUCH GERT
IPC: F16B35/00
Filed: 2009-09-18
Abstract: A clamping screw 2 used for fastening an electrical conductor in a tubular metallic terminal, where the terminal has a threaded hole in its upper wall and the threaded hole is designed to receive the clamping screw 2. The clamping screw 2 has a hemispherical recess at its end and the recess contains a freely rotating ball 10 which projects beyond the end of the screw 2 when the screw is in use. The diameter of the recess at the end of the clamping screw 2 corresponds to the diameter of the ball 10.
Patent NZ-579812-A (NZ)
Title: A method of manufacturing a caseless projectile for a small arms weapon
Inventor: HARRISON LESLIE MERVYN
IPC: F42B5/10
Filed: 2008-03-28
Abstract: A method of manufacturing, a caseless projectile for firing from a barrel of a small arms weapon is disclosed. The method includes forming a mould (32) having an interior surface and an opening at a first end. Then placing a core (42) into the opening in the mould to produce a casting void (43) between the core and the interior surface. Then introducing a liquefied solidifiable material into the casting void. Then relatively shaping the mould and the core, where upon removing the core a projectile body is formed having a closed nose. Then withdrawing the core from the projectile body to create an opposite open end in the projectile body and a cavity which opens onto the opposite open end. Then removing the projectile body from the mould. Lastly depositing a propellant in the cavity.
Patent NZ-587232-A (NZ)
Title: Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria
Inventor: FRAISSE LAURENT
IPC: A61K31/357
Filed: 2009-02-05
Abstract: Disclosed is the use of (i) a bisthiazolium salt of formula (VI) or a precursor thereof, wherein the variables are as defined in the specification, and (ii) artemisinin or a derivative thereof, chosen from artesunate, artemether, arteether, hydroartemisinin or dihydroartemisinin in the manufacture of a combination for the treatment and/or prevention of severe malaria.
Patent NZ-587430-A (NZ)
Title: A corrogated plastic detention chamber for stormwater runoff and related system and methods where the crests extend lengthwise
Inventor: COBB DANIEL P
IPC: E02B11/00
Filed: 2009-02-12
Abstract: Disclosed is a plastic, corrugated open bottom chamber (10) including one or more sub-corrugation features on corrugation crests (16) and/or corrugation valleys, stiffening fingers (14) on the bottom of chamber foot portions, a viewport configuration that intersects only a single corrugation crest and a unitary end wall. A method of producing chambers with or without a unitary end wall using a common mold tool is also provided.
Patent NZ-588502-A (NZ)
Title: Ventilator that becomes increasingly sensitive to the initiation of cycling as inspiration progresses
Inventor: BASSIN DAVID JOHN
IPC: A61M16/00
Filed: 2005-06-22
Abstract: A ventilator that delivers air at different pressures to a patient during inspiratory and expiratory cycles of breathing, and that cycles from inspiratory to expiratory operation as a function of the patient's respiratory flow. The ventilator becomes increasingly sensitive to the initiation of cycling as a function of time as inspiration progresses.
Patent NZ-589666-A (NZ)
Title: Organic compounds useful for the treatment of a disease mediated by the inhibition of aldosterone synthase
Inventor: ADAMS CHRISTOPHER
IPC: A61K31/4439
Filed: 2009-06-25
Abstract: Disclosed are indole-pyridine compounds represented by general formula (II). Examples of the compounds of formula (II) are: N-Methyl-N-[5-(1-methyl-3-cyano-1H-indol-2-yl)-pyridin-3-ylmethyl]-methanesulfonamide; N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-N-methylmethanesulfonamide; and 2,2,2-Trifluoro-ethanesulfonic acid [5-(6-chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-amide. The compounds are used to treat heart failure, congestive heart failure, arrhythmia, diastolic dysfunction, left ventricular diastolic dysfunction, diastolic heart failure, impaired diastolic filling, systolic dysfunction, ischemia, hypertropic cardiomyopathy, sudden cardiac death, myocardial and vascular fibrosis, impaired arterial compliance, myocardial necrotic lesions, vascular damage, myocardial infarction, left ventricular hypertrophy, decreased ejection fraction, cardiac lesions, vascular wall hypertrophy, endothelial thickening, fibrinoid necrosis of coronary arteries, renal dysfunction, liver diseases, cerebrovascular diseases, vascular diseases, retinopathy, neuropathy, insulinopathy, edema, endothelial dysfunction, baroreceptor dysfunction, migraine headaches, and hypertension. These are diseases or disorders all mediated by the inhibition of aldosterone synthase.
Patent NZ-592173-A (NZ)
Title: Fruit harvesting machine with a harvesting assembly supported on motorised structure with a suspension frame
Inventor: BERTHET JEAN-PAUL
IPC: A01D46/28
Filed: 2009-10-27
Abstract: Disclosed is a fruit-harvesting machine comprising a motorised support structure (1) and a harvesting assembly mounted on the structure by means of a suspension frame (2). The harvesting assembly comprising two shaker devices adapted to detach the harvest from the plant stocks and a system for recovering the detached harvest. The shaker devices delimiting transversely between them a harvesting space into which the stocks to be shaken are introduced successively to move in the space between a front opening and a rear opening of the space. The suspension frame comprises a rear part (6a) that is mounted on the support structure with at least one degree of freedom in the transverse direction, a front part (5a) of the frame being mounted on the support structure enabling transverse displacement of the rear part relative to the front part.
Patent NZ-592478-A (NZ)
Title: Process for synthesis of amino-methyl tetraline derivatives
Inventor: DURKIN KIERAN
IPC: C07C231/06
Filed: 2009-12-03
Abstract: Disclosed is a method for producing a serotonin receptor modulating compound of formula k1 or k2 (e.g., (R)-6-(3-fluoro-phenylsulfonyl)-1,2,3,4-tetrahydro-naphthalen-1-ylmethyl]-urea), wherein the substituents are as described within the specification. The resulting compounds are useful for enhancing cognitive memory in patients and for treating various central nervous system diseases.
Patent NZ-594096-A (NZ)
Title: Protective garment
Inventor: COTSOGLOU JONATHAN
IPC: A41D1/08
Filed: 2009-12-23
Abstract: 594096 A protective garment in particular for use by motorcyclists. The garment has a protective inner layer (3) and an outer layer which can be made of a fashionable material to give the garment a desirable appearance. The protective inner layer (3) is made of abrasion resistant material and lines substantially the whole of the inside of the garment. The inner layer (3) includes an arm portion and/or a leg portion (4), with the arm portion having a seam only on the inside of the arm portion such that the abrasion resistant material is continuous on the outside of the arm portion, and the leg portion (4) having a seam (6) only on the inside of the leg portion (4) such that the abrasion resistant material is continuous on the outside of the leg portion (4). The inner layer (3) is secured to the outer layer only at corresponding edges of the inner and outer layers which occur at openings of the garment.
Patent NZ-594759-A (NZ)
Title: A system and method of managing mapping information
Inventor: REVATHI RAGUNATHAN
IPC: G06F17/30
Filed: 2011-08-23
Abstract: A method for analysing and managing mapping information for data Extract-Transform-Load process and a data analysis and mapping system for data transformation are disclosed. The data analysis and mapping system comprises an analysis subunit hosted at each of a plurality of distributed nodes for extracting at least one source and target data structures and analysing inferences about data fields in source systems and target systems as tags and metadata for identifying related fields in the target systems and a data mapping management unit, implemented on a processor, and communicatively coupled to the plurality of distributed nodes for managing a mapping information associated with the at least one source and target data structures. The mapping management unit further comprises a management subunit adapted to receive extracted source and target data structures from the plurality of distributed nodes. The management subunit is further adapted to aggregate and define each received data structure in compliance with associated local data structure rules. The management subunit is further adapted to derive a set of global data structure compatibility rules to enable mapping between the source and target data structures, and the management subunit is further adapted to generate a mapping specification using the derived global data structure compatibility rules. The data analysis and mapping system further comprises a monitoring and validation subunit configured to iteratively verify the mapping specification until each of the plurality of distributed nodes approves each version of the mapping specification generation process, each version being made accessible to a plurality of nodes associated therewith
Patent NZ-596529-A (NZ)
Title: Chemical and biological agents for the control of molluscs
Inventor: ASOLKAR RATNAKAR
IPC: A01N63/27
Filed: 2010-04-20
Abstract: The disclosure relates to methods for controlling molluscs, members of the Gastropoda and Bivalvia classes particularly Dreissana species. The method involving the introduction to a location of a compound selected from a lactone (a), amide where the nitrogen forms part of a heterocyclic moiety (b), an amide selected from N‐cyclopentyldecanamide and N‐cyclopentyldecenamide (c), piliferolide A (d), 11‐hydroxy12‐ene‐octadecanoic acid (e) and N‐(decenoyl)pyrrolidine (f). Also provided are methods and compositions for increasing the efficacy of chemical and biological control for invasive molluscs in open waters, power plants, and drinking water treatment facilities under cold water conditions.
Patent NZ-596879-A (NZ)
Title: Tamper resistant dosage form comprising a matrix and melt - extruded particulates comprising a drug
Inventor: MOHAMMAD HASSAN
IPC: A61K9/16
Filed: 2010-06-07
Abstract: 596879 Disclosed herein is a dosage form comprising: melt-extruded particulates comprising a drug; and a matrix; wherein said melt-extruded particulates are present as a discontinuous phase in said matrix; said matrix comprises a continuous phase comprising a gel-forming agent; and said particulates further comprise a copolymer of acrylic acid alkyl esters and methacrylic acid alkyl esters or mixtures thereof. Additionally disclosed is the a process for preparing said dosage form, and the use of said dosage form in the treatment of pain, specifically wherein the drug is an opioid agonist, such as oxycodone.
Patent NZ-597025-A (NZ)
Title: Yeast, preparation method, composition, apparatus and uses thereof
Inventor: LENOIR CHRISTIAN
IPC: A21D8/04
Filed: 2010-06-17
Abstract: 597025 Disclosed is a method for producing dry yeast, wherein the dry yeast is in the form of spherules surrounded by a peripheral protective layer consisting essentially of dead cells, wherein said method comprises the steps of: dehydrating a mixture comprising yeast cream and a sodium chloride based brine using a dehydrating device so as to obtain dehydrated yeast, granulating the dehydrated yeast by extruding it in order to obtain extruded yeast, and drying the extruded yeast so as to obtain a dry yeast having a dry matter content greater than or equal to 92% by weight, wherein the drying is carried out batch wise and consists in: during a first drying step in a rotary drum dryer, passing a stream of hot air through the volume of yeast, and during a second drying step in a drying tower, sending hot air under the lower part of the volume of yeast.